Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Impact of medical eligibility criteria and OPTN policy on simultaneous liver kidney allocation and utilization

View through CrossRef
AbstractBackgroundOrgan Procurement and Transplantation Network (OPTN) implemented medical eligibility and safety‐net policy on 8/10/17 to optimize simultaneous liver‐kidney (SLK) utilization. We examined impact of this policy on SLK listings and number of kidneys used within 1‐yr. of receiving liver transplantation (LT) alone.Methods and resultsOPTN database (08/10/14‐06/12/20) on adults (N = 66 709) without previous transplant stratified candidates to listings for SLK or LT alone with pre‐LT renal dysfunction at listing (eGFR < 30 mL/min or on dialysis). Outcomes were compared for pre (08/10/14‐08/09/17) vs. post (08/10/17‐06/12/20) policy era. SLK listings decreased in post vs. pre policy era (8.7% vs. 9.6%; P < .001), with 22% reduced odds of SLK listing in the postpolicy era, with a decrease in all OPTN regions except regions 6 and 8, which showed an increase. Among LT‐alone recipients with pre‐LT renal dysfunction (N = 3272), cumulative 1‐year probability was higher in post vs. prepolicy period for dialysis (5.6% vs. 2.3%; P < .0001), KT listing (11.4% vs. 2.0%; P < .0001), and KT (3.7% vs. .25%; P < .0001). Sixty‐seven (2.4%) kidneys were saved in post policy era, with 18.1%, 16.6%, 4.3%, and 2.9% saving from regions 7, 2, 11, and 1, respectively.ConclusionMedical eligibility and safety‐net OPTN policy resulted in decreased SLK use and improved access to LT alone among those with pre‐LT renal dysfunction. Although decreased in postpolicy era, regional variation of SLK listings remains. In spite of increased use of KT within 1‐year of receiving LT alone under safety net, less number of kidneys were used without impact on patient survival in postpolicy era.
Title: Impact of medical eligibility criteria and OPTN policy on simultaneous liver kidney allocation and utilization
Description:
AbstractBackgroundOrgan Procurement and Transplantation Network (OPTN) implemented medical eligibility and safety‐net policy on 8/10/17 to optimize simultaneous liver‐kidney (SLK) utilization.
We examined impact of this policy on SLK listings and number of kidneys used within 1‐yr.
of receiving liver transplantation (LT) alone.
Methods and resultsOPTN database (08/10/14‐06/12/20) on adults (N = 66 709) without previous transplant stratified candidates to listings for SLK or LT alone with pre‐LT renal dysfunction at listing (eGFR < 30 mL/min or on dialysis).
Outcomes were compared for pre (08/10/14‐08/09/17) vs.
post (08/10/17‐06/12/20) policy era.
SLK listings decreased in post vs.
pre policy era (8.
7% vs.
9.
6%; P < .
001), with 22% reduced odds of SLK listing in the postpolicy era, with a decrease in all OPTN regions except regions 6 and 8, which showed an increase.
Among LT‐alone recipients with pre‐LT renal dysfunction (N = 3272), cumulative 1‐year probability was higher in post vs.
prepolicy period for dialysis (5.
6% vs.
2.
3%; P < .
0001), KT listing (11.
4% vs.
2.
0%; P < .
0001), and KT (3.
7% vs.
.
25%; P < .
0001).
Sixty‐seven (2.
4%) kidneys were saved in post policy era, with 18.
1%, 16.
6%, 4.
3%, and 2.
9% saving from regions 7, 2, 11, and 1, respectively.
ConclusionMedical eligibility and safety‐net OPTN policy resulted in decreased SLK use and improved access to LT alone among those with pre‐LT renal dysfunction.
Although decreased in postpolicy era, regional variation of SLK listings remains.
In spite of increased use of KT within 1‐year of receiving LT alone under safety net, less number of kidneys were used without impact on patient survival in postpolicy era.

Related Results

[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Ablation of optineurin impairs metabotropic glutamate receptor 5 signaling in mouse hippocampus
Ablation of optineurin impairs metabotropic glutamate receptor 5 signaling in mouse hippocampus
Optineurin (OPTN) is a ubiquitously expressed autophagy adaptor that forms a functional interactome with Group I metabotropic glutamate receptors (mGluR1 and 5), members of the Gα ...
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
Rethinking Anticoagulation in Kidney Disease and Kidney Transplantation
BackgroundA clinical dilemma exists in patients with CKD, ESKD, and after kidney transplantation, as they face concurrent risks of both thromboembolic and hemorrhagic complications...
OPTN attenuates the neurotoxicity of abnormal Tau protein by restoring autophagy
OPTN attenuates the neurotoxicity of abnormal Tau protein by restoring autophagy
AbstractOPTN is an autophagy receptor involved in autophagic degradation. Here we studied the role of OPTN in attenuating the neurotoxicity induced by mutated Tau protein. We const...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Generation of CRISPR-Cas9 Engineered OPTNE478G Human Embryo Stem Cell Line for Investigation into Mitophagy Defects
Generation of CRISPR-Cas9 Engineered OPTNE478G Human Embryo Stem Cell Line for Investigation into Mitophagy Defects
Background: Optineurin (OPTN) is a mitophagy adaptor protein linking damaged, ubiquitinated mitochondria to autophagosomes for lysosomal degradation. The E50K and E478G OPTN mutati...
Piece by piece: Collaborative mosaic-making for inclusive policy development
Piece by piece: Collaborative mosaic-making for inclusive policy development
This report sets out the findings from one of four projects commissioned by Wellcome Policy Lab to pilot creative approaches to policy development. In this project, Scientia Script...

Back to Top